In Feasibility Study for Large, Prospective, Real-World Trial, Masimo SET® Performed Accurately on Critically Ill Adult ICU Patients of All Skin Tones The INSPIRE Trial Prospectively Assesses Pulse ...

Sanofi ($SNYNF) announced an update on their ongoing clinical study. Study Overview Sanofi has completed an observational study titled “Cognitive ...

A minimally invasive surgical procedure for glaucoma designed to reduce intraocular pressure (IOP) has been found to have a high degree of success and significantly reduce the use of drugs for the ...

Ruxolitinib cream shows rapid, significant repigmentation in NSV, aligning with phase 3 trial outcomes and suggesting first-line therapy potential, especially for facial involvement. The study's ...

Cardiovascular disease still claims more lives than any other illness, and many adults living with obesity or type 2 diabetes carry a heavy risk of heart attack and stroke. Two medications, ...

Tarlatamab showed promising antitumor activity in heavily pretreated SCLC patients, including those with untreated brain metastases. Real-world data indicated higher rates of CRS and ICANS compared to ...

HIV and tuberculosis (TB) treatment programs have always relied on clinical trials to understand whether treatment ...

Lutathera showed antitumor activity in metastatic BP-NETs, with partial responses in 17% of patients and stable disease in 30%. The study reported a median progression-free survival of 10.8 months and ...

Researchers have unveiled a new magnetic cloaking device that can render sensitive objects invisible to detection.

In one of the first real-world studies, Tirzepatide shows impressive weight loss results for people without diabetes—shedding nearly 13% of body weight in just six months. Study: Real-world use and ...

The INSPIRE Trial Prospectively Assesses Pulse Oximeter Accuracy Using a Unique Real-world Study Design and in the Feasibility Study Showed No Clinically Significant Bias Between Patients with Light ...